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Smortality. ROC curve analysis was performed to detect the best cut-off value of NLR
in the prediction of in-hospital mortality.
Results: The mean age of the study population was 6113.8 years (M: 30, F: 17).
Twenty-eight patients underwent operation due to type A aortic dissection. The rest of
the patients with chronic type B dissection were followed-up under medical treatment.
Nine patients died during hospitalization; higher levels of NLR was observed in these
patients compared to the patients who did survive (21.818.5 versus 8.15.6;
p¼0.008). Twelve patients (26%) had pericardial effusion on admission and NLR was
signiﬁcantly higher in these patients than the patients wihout effusion (17.310.7
versus 9.711.8; p¼0.02). Multivariate analysis showed that age 65 years, aortic
diameter 49 mm, pericardial effusion, history of smoking, systolic blood pressure
<90 mmHg were associated with in-hospital mortality. NLR value > 8 yielded an
AUC value of 0.795 (95% CI 0.623-0.966; p¼0.009) which demonstrated a sensitivity
of 78% and speciﬁcity of 65 % for the prediction of mortality.
Conclusıons: NLR may be associated with in-hospital cardiac events in patients with
acute aortic dissection.
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Background: Increased epicardial adipose tissue thickness (EATT), a component of
body visceral adiposity, has been suggested to increase the likelihood of lifetime
cardiovascular disease risk. Women with gestational diabetes mellitus (GDM) have
higher risk of developing type 2 diabetes and, consequently, a higher cardiovascular
risk. We searched if the patients with GDM have increased EATT, along with its
relation to the measures of insulin sensitivity.
Method: 96 women with GDM, 69 women with healthy pregnant aged between 19
and 44 years were enrolled. They all underwent physical examination and hormonal
and metabolic evaluation, as well as standard echocardiography and EATT. EATT
was measured by echocardiography above the free wall of the right ventricle. Age,
smoking status and pregestational body mass index (pre-BMI) were obtained. Insulin
resistance was assessed by homeostasis model assessment of insulin resistance
(HOMA-IR) formula. Kruskal-Wallis followed by Bonferroni-corrected post hoc
Mann-Whitney U tests were used to analyze the data.
Results: The women with GDM were signiﬁcantly older than the non-diabetic
pregnant women (p¼0.001). The HOMA index and basal insulin levels were signif-
icantly higher in the GDM group than the non-diabetic group (p <0.0001 and
p <0.0001, respectively). GDM subjects had higher EATT (p<0.001) but other
echocardiographic parameters were not statistically different.
Conclusıon: Thickness of the EAT is increased in patients with GDM in conjunction
with insulin resistance. Further studies are needed to clarify the relation of EATT and
cardiovascular risk in patients with GDM.Table 1
GDM Patients Non-Diabetics p
EATT (mm) 4.7  0,88 3.8  0.88 <0.001
p<0.05 is statistically signiﬁcant GDM: Gestational Diabetes Mellitus EATT: Epicardial Adipose
Tissue ThicknessPP-126
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Introductıon: Recent studies were reported on relationships of pulmonary function
with hypertension, type 2 diabetes, low density lipoprotein cholesterol, obesity and
insulin resistance as diagnostic criteria for metabolic syndrome and changes in the
pulmonary function. The purpose of this study was to investigate the associations
between components of metabolic syndrome with pulmonary function and functional
capacity.
Materıal-Methods: Twenty ﬁve subjects with metabolic syndrome (mean age:
43.3010.3 years) were included in our study. Metabolic syndrome is diagnosed on
the basis of the Asia criteria of the American Heart Association/National Heart,JACC Vol 62/18/Suppl C j October 26–29, 2013 j TSC Abstracts/POSTLung, and Blood Institute. The anthropometric values (body mass index, waist and
hip circumference, waist/hip ratio, body fat percentage, lean muscle mass) of
subjects were determined. The total cholesterol, triglyceride, high-density lipo-
protein cholesterol, low-density lipoprotein cholesterol and fasting blood sugar
were measured with blood test. The vital capacity (VC), inspiratory capacity (IC),
forced vital capacity (FVC), forced expiratory volume for 1 second (FEV1), and
FEV1/ FVC ratio, maximal inspiratory and expiratory muscle strengths (MIP,
MEP) were evaluated. Functional capacity was assessed using 6-minute walk test
(6MWT) distance.
Results: Both waist circumference and waist/hip ratio were adversely correlated with
VC% (r¼,503, p¼0.01; r¼-,561, p¼0.004, respectively) and FVC% (r¼-,468,
p¼0.018; r¼.-,405, p¼0.045, respectively). There were negative relationships
between waist circumference with FEV1% (r¼-,456 p¼0.022) and hip circumference
with FEV1 (r¼-,499, p¼0.011). It was observed that there were signiﬁcant adverse
correlations between body fat percentage with MIP (r¼-,488, p¼0.013), VC (r¼-,587,
p¼0.002), IC (r¼-,398, p¼0.049), FVC (r¼-,678, p¼0.000); lean muscle mass with
MIP (r¼-,447, p¼0.025); HbA1c with MIP (r¼-,418, p¼0.038), MIP% (r¼-,488,
p¼0.013), MEP% (r¼-,464, p¼0.020). In addition, there were negative correlations
between hip circumference and body fat percentage with 6MWT distance (r¼-,521,
p¼0.03; r¼.-,730, p¼0.000, respectively) and there was positive correlation lean
muscle mass with 6MWT distance (r¼,686, p¼0.000).
Conclusıon: These results indicate that the metabolic syndrome impacts some
pulmonary function parameters, inspiratory and expiratory muscle strengths and
functional capacity negatively, Therefore, pulmonary function, inspiratory muscle
strength and functional capacity should be included in the assessments and treatments
intended for them should be included in treatment programs in patients with metabolic
syndrome.
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Objectıves: Breast cancer is the most common type of cancer in women. Treatment of
breast cancer includes surgery, chemotherapy and radiotherapy. These treatment
modalities have beneﬁcial effect on prognosis with the cost of potential serious cardiac
side effects. Cardiac effects are usually recognised after clinical symptom or sign
occurence. However, subclinical cardiac side effects can be determined by electro-
cardiography or echocardiography even in the early period. In this study we aimed to
determine the potential subclinical cardiotoxic effects of chemotherapy in patients
with breast cancer during early period.
Method: Fifty-one patients consecutively enrolled to the sudy. All patient were
diagnosed as breast cancer at oncology hospital in University of Gaziantep. All
patients were taken lower cemotherapy dosage than well known cardiac safety dosage
limits. The chemotherapy type, total dose and number of cure and region of radiation
therapy were determined in all patients. Before chemotherapy all of the patients
underwent to detailed ECG and ECHO examinations. After 6 months detailed ECG
and ECHO examinations were repeated and compared with baseline values.
Results: Our study results are as follows: statistically signiﬁcant decrease in ejection
fraction was found after treatment (62.3%3.3 versus 59.95.9%, p:0.002,).
Signiﬁcant increase in the transmitral A ﬂow velocity and signiﬁcant decrease of E / A
ratio were observed on Doppler ECHO analysis (77.419.1 cm / sec versus
86.018.0 cm / sec, p<0.001; 1.010.3 versus 0.90.2, p:0.03, respectively). On
tissue Doppler analysis we observed that signiﬁcant reduction in the value of E’ and
signiﬁcantly increase E / E’ ratio were present (12.53.6 cm / sec versus 10.72.9 cm
/ sec, p:0.001; 6.62.9 versus 7.73.3, p:0.04, respectively). On electrocardiographic
examination, heart rate was signiﬁcantly increased (8513 / min versus 8513 / min,
p:0.02), and there was prolongation of PR interval which was not reached to the
statistical signiﬁcance (14316 ms versus 14720 ms, p ¼ 0, 09).
Conclusıon: We evaluated the subclinical cardiac adverse effects of chemotherapy in
subjects with breast cancer. We found that chemotherapy has detrimental subclinical
effect on both of systolic and diastolic function in early six months period despite the
prescription of lower dosage of cemothearpy than well known cardiac safety dosage
limits. During post chemotherapy period, echocardiographic screening for subtle
change in echocardiographic parameters should alert physician for possible cardiac
toxicity of chemoradiotherapy.ERS C131
